April
20
Neurolens Measures Its One Millionth Patient
DALLAS, April 20, 2023 – Neurolens, a company commercializing innovative solutions to optimize vision, announced...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.